Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis

An increasing number of breast cancer patients develop brain metastases (BM). Standard-of-care treatments are largely inefficient, and breast cancer brain metastasis (BCBM) patients are considered untreatable. Immunotherapies are not successfully employed in BCBM, in part because breast cancer is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Uceda-Castro, Rebeca, Margarido, Andreia S., Cornet, Lesley, Vegna, Serena, Hahn, Kerstin, Song, Ji-Ying, Putavet, Diana A., van Geldorp, Mariska, Çitirikkaya, Ceren H., de Keizer, Peter L.J., ter Beek, Leon C., Borst, Gerben R., Akkari, Leila, van Tellingen, Olaf, Broekman, Marike L.D., Vennin, Claire, van Rheenen, Jacco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729880/
https://www.ncbi.nlm.nih.gov/pubmed/36384097
http://dx.doi.org/10.1016/j.xcrm.2022.100821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729880/
https://www.ncbi.nlm.nih.gov/pubmed/36384097
http://dx.doi.org/10.1016/j.xcrm.2022.100821

Ejemplares similares